NEUROVANCE, INC.
Profile
Company Names
NEUROVANCE, INC.
Addresses
43 THORNDIKE STREET, SUITE S1-3, CAMBRIDGE, MA 02141
Phone Numbers
617-758-0300
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER TECHNOLOGY
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$35,032,341.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-12-23
$554,280.00
$554,280.00
$0.00
Debt
3
2016-02-24
$7,500,000.00
$16,000,000.00
$8,500,000.00
Debt
2
2012-10-11
$26,499,997.00
$26,499,997.00
$0.00
Equity
1
2012-03-02
$478,064.00
$478,064.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY
BAILEY
DIRECTOR, EXECUTIVE OFFICER
ANDREW
BAKER
DIRECTOR
TIMOTHY
J.
BARBERICH
DIRECTOR
GREGG
BELOFF
EXECUTIVE OFFICER
FRANKLIN
P.
BYMASTER
EXECUTIVE OFFICER
JOSHUA
FUNDER
DIRECTOR
FRANK
GENTILE
DIRECTOR
ANTHONY
A.
MCKINNEY
EXECUTIVE OFFICER, DIRECTOR
CAMPBELL
MURRAY
DIRECTOR
ALIOS BIOPHARMA INC
| TOKAI PHARMACEUTICALS INC
| AILERON THERAPEUTICS INC
| BIORELIX INC
| EUTHYMICS BIOSCIENCE INC
| AKEBIA THERAPEUTICS, INC.
| AERPIO THERAPEUTICS, INC.
| NEUROVANCE, INC.
| EBI LIFE SCIENCES, INC.
| IMAGINAB, INC.
| GALERA THERAPEUTICS, INC.
| BIONANO GENOMICS, INC
| EUTHYMICS BIOSCIENCE, INC.
| ICEBREAKER HEALTH, INC.
| ANNEXON, INC.
| TSCAN THERAPEUTICS, INC.
| RENOVACOR, INC.
| LIGHTHOUSE PHARMACEUTICALS, INC.
DANIEL
OMSTEAD
DIRECTOR
THOMAS
A.
SHEA
EXECUTIVE OFFICER
BRIGITTE
SMITH
DIRECTOR
PAUL
WEISS
DIRECTOR
EUTHYMICS BIOSCIENCE INC
| PIPELINE FINANCE LLC
| AKEBIA THERAPEUTICS, INC.
| GINNIE ACCEPTANCE COMPANY, LLC
| AERPIO THERAPEUTICS, INC.
| NEUROVANCE, INC.
| EBI LIFE SCIENCES, INC.
| TAMIR BIOTECHNOLOGY, INC.
| WEST HILL STRATEGIC BOND FUND, LP
| EUTHYMICS BIOSCIENCE, INC.
| FLUGEN INC
| INVENRA INC.
| VENTURE INVESTORS HEALTH FUND 6 LIMITED PARTNERSHIP
| TEN BAY BIO, INC.
| VENTURE INVESTORS HEALTH FUND 7 LIMITED PARTNERSHIP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

